190 related articles for article (PubMed ID: 20464378)
1. Comparing and contrasting the effects of strontium ranelate and other osteoporosis drugs on microarchitecture.
Ferrari S
Osteoporos Int; 2010 Jun; 21 Suppl 2():S437-42. PubMed ID: 20464378
[TBL] [Abstract][Full Text] [Related]
2. Strontium ranelate improves bone microarchitecture in osteoporosis.
Hamdy NA
Rheumatology (Oxford); 2009 Oct; 48 Suppl 4():iv9-13. PubMed ID: 19783592
[TBL] [Abstract][Full Text] [Related]
3. Effects of strontium ranelate and alendronate on bone microstructure in women with osteoporosis. Results of a 2-year study.
Rizzoli R; Chapurlat RD; Laroche JM; Krieg MA; Thomas T; Frieling I; Boutroy S; Laib A; Bock O; Felsenberg D
Osteoporos Int; 2012 Jan; 23(1):305-15. PubMed ID: 21909729
[TBL] [Abstract][Full Text] [Related]
4. Strontium ranelate and alendronate have differing effects on distal tibia bone microstructure in women with osteoporosis.
Rizzoli R; Laroche M; Krieg MA; Frieling I; Thomas T; Delmas P; Felsenberg D
Rheumatol Int; 2010 Aug; 30(10):1341-8. PubMed ID: 20512336
[TBL] [Abstract][Full Text] [Related]
5. Trabecular reorganization in consecutive iliac crest biopsies when switching from bisphosphonate to strontium ranelate treatment.
Jobke B; Burghardt AJ; Muche B; Hahn M; Semler J; Amling M; Majumdar S; Busse B
PLoS One; 2011; 6(8):e23638. PubMed ID: 21858188
[TBL] [Abstract][Full Text] [Related]
6. Strontium ranelate decreases the incidence of new caudal vertebral fractures in a growing mouse model with spontaneous fractures by improving bone microarchitecture.
Geoffroy V; Chappard D; Marty C; Libouban H; Ostertag A; Lalande A; de Vernejoul MC
Osteoporos Int; 2011 Jan; 22(1):289-97. PubMed ID: 20204596
[TBL] [Abstract][Full Text] [Related]
7. Potential anti-catabolic and anabolic properties of strontium ranelate.
Mentaverri R; Brazier M; Kamel S; Fardellone P
Curr Mol Pharmacol; 2012 Jun; 5(2):189-94. PubMed ID: 21787286
[TBL] [Abstract][Full Text] [Related]
8. Differing effects of PTH 1-34, PTH 1-84, and zoledronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis: an 18-month open-labeled observational study using HR-pQCT.
Hansen S; Hauge EM; Beck Jensen JE; Brixen K
J Bone Miner Res; 2013 Apr; 28(4):736-45. PubMed ID: 23044908
[TBL] [Abstract][Full Text] [Related]
9. Strontium ranelate in osteoporosis.
Reginster JY
Curr Pharm Des; 2002; 8(21):1907-16. PubMed ID: 12171530
[TBL] [Abstract][Full Text] [Related]
10. Impact of treatments for postmenopausal osteoporosis (bisphosphonates, parathyroid hormone, strontium ranelate, and denosumab) on bone quality: a systematic review.
Gallacher SJ; Dixon T
Calcif Tissue Int; 2010 Dec; 87(6):469-84. PubMed ID: 20872215
[TBL] [Abstract][Full Text] [Related]
11. Effects of strontium ranelate administration on bisphosphonate-altered hydroxyapatite: Matrix incorporation of strontium is accompanied by changes in mineralization and microstructure.
Busse B; Jobke B; Hahn M; Priemel M; Niecke M; Seitz S; Zustin J; Semler J; Amling M
Acta Biomater; 2010 Dec; 6(12):4513-21. PubMed ID: 20654744
[TBL] [Abstract][Full Text] [Related]
12. Strontium ranelate: a new paradigm in the treatment of osteoporosis.
Reginster JY; Deroisy R; Jupsin I
Drugs Today (Barc); 2003 Feb; 39(2):89-101. PubMed ID: 12698204
[TBL] [Abstract][Full Text] [Related]
13. Strontium ranelate: an increased bone quality leading to vertebral antifracture efficacy at all stages.
Ortolani S; Vai S
Bone; 2006 Feb; 38(2 Suppl 1):19-22. PubMed ID: 16455319
[TBL] [Abstract][Full Text] [Related]
14. Strontium ranelate: a physiological approach for an improved bone quality.
Ammann P
Bone; 2006 Feb; 38(2 Suppl 1):15-8. PubMed ID: 16455318
[TBL] [Abstract][Full Text] [Related]
15. Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats.
Ammann P; Shen V; Robin B; Mauras Y; Bonjour JP; Rizzoli R
J Bone Miner Res; 2004 Dec; 19(12):2012-20. PubMed ID: 15537445
[TBL] [Abstract][Full Text] [Related]
16. Strontium ranelate: a dual mode of action rebalancing bone turnover in favour of bone formation.
Marie PJ
Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S11-5. PubMed ID: 16735840
[TBL] [Abstract][Full Text] [Related]
17. Strontium ranelate enhances callus strength more than PTH 1-34 in an osteoporotic rat model of fracture healing.
Habermann B; Kafchitsas K; Olender G; Augat P; Kurth A
Calcif Tissue Int; 2010 Jan; 86(1):82-9. PubMed ID: 19960189
[TBL] [Abstract][Full Text] [Related]
18. [New bone density conservation agents for osteoporosis under research and development: Strontium ranelate].
Shiraki M
Nihon Rinsho; 2007 Nov; 65 Suppl 9():447-53. PubMed ID: 18161147
[No Abstract] [Full Text] [Related]
19. Improvement in bone strength parameters. The role of strontium ranelate.
Tournis S
J Musculoskelet Neuronal Interact; 2007; 7(3):266-7. PubMed ID: 17947810
[TBL] [Abstract][Full Text] [Related]
20. Hip cortical thickness assessment in postmenopausal women with osteoporosis and strontium ranelate effect on hip geometry.
Briot K; Benhamou CL; Roux C
J Clin Densitom; 2012; 15(2):176-85. PubMed ID: 22321661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
